Welcome to Keyholder Funding LTD
Keyholder specialise in opportunities to invest in an asset-backed Cancer breakthrough technology portfolio. Through our expertise and unique funding structure we provide investors with an unrivalled return on investment with minimised risk and prioritised return of capital.
The developments chosen to be in this investment programme are subjected to an extremely rigorous selection process.
Over 60 important assets have been examined and scrutinised and, as a result, there are now two projects available, with two more due in Autumn 2018. There is a continuous process of selection and due diligence.
Keyholder Funding Limited does not give financial advice.